1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow PASC Post Acute Sequelae of COVID 19: new trials by email Literature Review of PASC Post Acute Sequelae of COVID 19 trials Research Report on PASC Post Acute Sequelae of COVID 19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 30 | 2026-12-30 | 2026-10-16 |
| Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation accelerated intermittent theta burst stimulation - Long COVID, Long COVID Syndrome | Phase 2 | Recruiting | University of New Mexico | 60 | 2025-07-07 | 2026-07-15 |
| Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 Valacyclovir celecoxib dose 1, Valacyclovir celecoxib dose 2, Placebo - Long COVID, PASC Post Acute Sequelae of COVID 19 | Phase 2 | Completed | Bateman Horne Center | 59 | 2023-10-15 | 2025-01-22 |
Post-Acute COVID-19 Syndrome (3)
COVID-19 (3) · Chronic Disease (3) · Coronaviridae Infections (3) · Coronavirus Infections (3) · Disease Attributes (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Pneumonia (3) · Pneumonia, Viral (3) · Post-Infectious Disorders (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3)
DMAC2L protein, human (1) · Taurine (1)
Bateman Horne Center (1) · University of Alberta (1) · University of New Mexico (1)
United States (2)
Davin Quinn, MD (1) · Lawrence Richer, MD, MSc (1) · Lucinda Bateman, MD (1)